A
Arthur Schwartzbard
Researcher at New York University
Publications - 53
Citations - 1587
Arthur Schwartzbard is an academic researcher from New York University. The author has contributed to research in topics: Diabetes mellitus & Coronary artery disease. The author has an hindex of 18, co-authored 52 publications receiving 1359 citations. Previous affiliations of Arthur Schwartzbard include Veterans Health Administration & VA NY Harbor Healthcare System.
Papers
More filters
Journal ArticleDOI
Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiographic study
Edward S. Katz,Theofanis Tsiamtsiouris,Robert M. Applebaum,Arthur Schwartzbard,Paul A. Tunick,Itzhak Kronzon +5 more
TL;DR: Surgical LAA ligation is frequently incomplete, and the similar incidence of incomplete ligation detected immediately postoperative and at various times thereafter suggest that this results from an intraoperative phenomenon rather than from gradual dehiscence of sutures over years.
Journal ArticleDOI
Fish oil for the treatment of cardiovascular disease.
TL;DR: This review will focus on the current clinical uses of fish oil and provide an update on their effects on triglycerides, coronary artery disease, heart failure, and arrhythmia, and explore the dietary sources of fishOil as compared with drug therapy, and discuss the use ofFish oil products in combination with other commonly used lipid-lowering agents.
Journal ArticleDOI
Primary Prevention of Cardiovascular Disease in Diabetes Mellitus
TL;DR: Evidence and guidelines for lifestyle and CVD risk factor management has the potential to significantly reduce the burden of CVD among patients with T2D are summarized.
Journal ArticleDOI
Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials
Sripal Bangalore,Bora Toklu,Eugenia Gianos,Arthur Schwartzbard,Howard Weintraub,Gbenga Ogedegbe,Franz H. Messerli +6 more
TL;DR: In patients with hypertension, a on-treatment systolic BP target of <130 mm Hg achieved optimal balance between efficacy and safety, and was ranked #1 and #2, respectively, as the most efficacious target.
Journal ArticleDOI
Changes in Lipid Profile of Obese Patients Following Contemporary Bariatric Surgery: A Meta-Analysis.
Sean P. Heffron,Amar Parikh,Alexander Volodarskiy,Christine Ren-Fielding,Arthur Schwartzbard,Joseph Nicholson,Sripal Bangalore +6 more
TL;DR: In this article, the effects of contemporary bariatric surgery on serum lipids have not been systematically characterized, and the primary outcome was change in lipids from baseline to 1 year after surgery.